Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients: Open-label, Local, Phase IV Study
Conditions
Interventions
S-NOR (s-amlodipine) 2,5 mg & 5 mg tablet
Locations
1
Turkey (Türkiye)
Istanbul University Istanbul Medical Faculty Clinical Pharmacology Department
Istanbul, Fatih, Turkey (Türkiye)
Start Date
March 20, 2013
Primary Completion Date
February 14, 2017
Completion Date
February 14, 2017
Last Updated
June 15, 2018
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Neutec Ar-Ge San ve Tic A.Ş
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions